Fanjie Qu

No. 40 Qianshan Road, Ganjingzi District
Dalian, 116033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Research progress on the correlation between OPN and immune escape of gastric cancer.

Research progress on the correlation between OPN and immune escape of gastric cancer.

Journal: Clinical and experimental medicine
Published: September 16, 2025

Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer.

Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer.

Journal: OncoTargets and therapy
Published: October 11, 2024

Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases.

Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 10, 2023

Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.

Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.

Journal: Anti-cancer drugs
Published: February 02, 2023

A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance.

A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance.

Journal: Anti-cancer drugs
Published: September 14, 2021

Tislelizumab combined with apatinib in the treatment of advanced renal clear cell carcinoma: a case report.

Tislelizumab combined with apatinib in the treatment of advanced renal clear cell carcinoma: a case report.

Journal: Anti-cancer drugs
Published: August 30, 2021

An elderly advanced non-small cell lung cancer patient harboring rare epidermal growth factor receptor mutations L861R benefited from afatinib: A case report.

An elderly advanced non-small cell lung cancer patient harboring rare epidermal growth factor receptor mutations L861R benefited from afatinib: A case report.

Journal: Medicine
Published: August 27, 2021

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.

Journal: Medicine
Published: April 26, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026